QuantumScape
QS
$5.98
+4.91%
QuantumScape Corporation is a developer of next-generation solid-state lithium-metal batteries for electric vehicles and other applications, operating in the auto parts industry. The company is a pioneer in solid-state battery technology, aiming to offer greater energy density, faster charging, and enhanced safety compared to conventional lithium-ion batteries. Currently, the investor narrative is dominated by the company's strategic shift to a licensing model, which has delayed its timeline to 2029 and raised concerns about its high cash burn and lack of revenue, making it a highly speculative investment. Recent news highlights both the potential of its technology, validated by a partnership with Honda, and the significant execution risks ahead.…
QS
QuantumScape
$5.98
Related headlines
Investment Opinion: Should I buy QS Today?
Rating: Sell. QuantumScape is a highly speculative stock with no revenue, a delayed timeline to 2029, and a consensus recommendation of 'none' with an average target price of $6.66, implying only 7.6% upside. The bearish case is supported by the company's negative free cash flow of -$281.7 million TTM, zero gross margin, and a price-to-book ratio of 5.13 that is near historical highs, suggesting the stock is overvalued relative to its fundamentals. The recent downgrades from Evercore ISI and HSBC further reinforce the cautious outlook.
Sign up to view all
QS 12-Month Price Forecast
The AI assessment is bearish due to the company's lack of revenue, heavy cash burn, and high valuation. The stock's price-to-book ratio of 5.13 is not justified by fundamentals, and the delayed timeline to 2029 increases execution risk. While the Honda partnership is a positive signal, it is insufficient to offset the financial challenges. The stance would be upgraded to neutral if the company signs a major licensing deal or reduces cash burn significantly, and to bullish if it achieves a technical breakthrough that accelerates commercialization.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QuantumScape's 12-month outlook, with a consensus price target around $6.66 and implied upside of +11.4% versus the current price.
Average Target
$6.66
0 analysts
Implied Upside
+11.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$3 - $10
Analyst target range
QuantumScape has coverage from 8 analysts, with a consensus recommendation of 'none' and an average target price of $6.66, implying a 7.6% upside from the current price of $6.19. The distribution includes 1 Buy, 4 Hold, and 3 Sell ratings, indicating a cautious sentiment. The low target is $2.50, representing a 59.6% downside, while the high target is $10.00, a 61.6% upside. The wide range reflects high uncertainty about the company's future, with the low target pricing in potential failure or dilution, and the high target assuming successful commercialization. Recent ratings actions show a mix of downgrades and holds, with Evercore ISI downgrading from Outperform to In Line in November 2025, and HSBC downgrading to Reduce in February 2026, indicating a negative trend in analyst sentiment.
Bulls vs Bears: QS Investment Factors
QuantumScape presents a classic high-risk, high-reward speculative investment. The bull case rests on its pioneering solid-state technology, validated by the Honda partnership, and a strong balance sheet with minimal debt. However, the bear case is compelling: zero revenue, a cash burn of ~$70 million per quarter, a delayed timeline to 2029, and deteriorating analyst sentiment. Currently, the bearish evidence is stronger, as the company faces significant execution risks and a long path to profitability. The most critical tension is whether QuantumScape can successfully transition to a licensing model and secure commercial partnerships before its cash reserves deplete, which would determine if the stock is a revolutionary opportunity or a value trap.
Bullish
- Strategic Honda Partnership Validates Technology: In June 2026, Honda's R&D arm announced a partnership to advance QuantumScape's solid-state battery technology, providing external validation of its technical approach. This collaboration could accelerate development and open doors to future licensing deals, supporting the company's shift to an asset-light licensing model.
- Strong Liquidity with $15.95 Current Ratio: QuantumScape maintains a current ratio of 15.95, indicating ample short-term liquidity to fund operations for the foreseeable future. With a debt-to-equity ratio of just 0.061, the company has minimal leverage, reducing financial distress risk despite negative cash flows.
- Losses Narrowing Sequentially: Net losses improved from -$114.7 million in Q2 2025 to -$100.8 million in Q1 2026, a 12% reduction, while EBITDA losses also narrowed from -$94.7 million to -$85.6 million. This trend suggests improving cost discipline, though the company remains far from profitability.
- High Analyst Target Offers 61.6% Upside: The highest analyst target price is $10.00, implying a 61.6% upside from the current price of $6.19. This reflects the potential for significant re-rating if the company achieves key technical milestones, such as successful commercialization of its solid-state batteries.
Bearish
- Zero Revenue and Heavy Cash Burn: QuantumScape has generated no revenue, with Q1 2026 revenue at $0, while burning approximately $70 million per quarter, leading to a TTM free cash flow of -$281.7 million. This unsustainable burn rate requires continuous external financing, diluting shareholders and risking solvency if capital markets tighten.
- Delayed Timeline to 2029 Raises Execution Risk: The company's shift to a licensing model has pushed its commercialization timeline to 2029, increasing the risk of technological obsolescence or competitive displacement. This long horizon without revenue makes the stock highly speculative and vulnerable to negative news.
- Analyst Sentiment Deteriorating: Recent downgrades include Evercore ISI (Outperform to In Line) and HSBC (to Reduce), reflecting growing skepticism. With only 1 Buy, 4 Hold, and 3 Sell ratings, the consensus is cautious, and the average target price of $6.66 offers just 7.6% upside, limiting near-term reward.
- Stock in Downtrend with High Volatility: The stock is down 31.9% over the past year and 44.0% YTD, trading near its 52-week low of $4.77. With a beta of 2.689, it is highly volatile, amplifying losses in market downturns, and the negative relative strength versus the S&P 500 indicates persistent underperformance.
QS Technical Analysis
QuantumScape's stock is in a clear downtrend, with a 1-year price change of -31.9% and a 6-month change of -19.9%. The current price of $6.19 is near the lower end of its 52-week range, sitting at approximately 10.6% above the 52-week low of $4.77 and 67.5% below the 52-week high of $19.07. This positioning near the lows suggests a falling knife scenario, where value investors might see opportunity but momentum traders remain cautious. The stock's beta of 2.689 indicates it is significantly more volatile than the market, amplifying both upside and downside moves.
Beta
2.69
2.69x market volatility
Max Drawdown
-73.5%
Largest decline past year
52-Week Range
$5-$19
Price range past year
Annual Return
-24.0%
Cumulative gain past year
| Period | QS Return | S&P 500 |
|---|---|---|
| 1m | +1.9% | +2.5% |
| 3m | -27.1% | +2.7% |
| 6m | -13.1% | +11.1% |
| 1y | -24.0% | +20.5% |
| ytd | -45.9% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QS Fundamental Analysis
QuantumScape has no revenue, with quarterly revenue of $0 for Q1 2026, and the company has consistently reported net losses, with Q1 2026 net income of -$100.8 million. The gross profit is negative at -$14.76 million, reflecting the high cost of developing its technology. The company's net margin is 0% due to no revenue, and its operating margin is also 0%, indicating that it is not yet generating any sales. The trajectory shows losses narrowing slightly from -$114.7 million in Q2 2025 to -$100.8 million in Q1 2026, but the company remains far from profitability. The balance sheet shows a debt-to-equity ratio of 0.061, indicating low leverage, and a current ratio of 15.95, suggesting strong liquidity. However, free cash flow is deeply negative at -$281.7 million TTM, and the company is burning cash at a rate of about $70 million per quarter, relying on external financing and its cash reserves to fund operations.
Quarterly Revenue
$0.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-281657000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QS Overvalued?
Given that QuantumScape has negative net income, the price-to-sales ratio is not applicable as revenue is zero, so we use the price-to-book ratio as the primary valuation metric. The current PB ratio is 5.13, which is high relative to the company's historical range, indicating that the market is pricing in significant future growth. The forward PE is -9.10, and the trailing PE is -13.71, both negative due to losses, but the gap between them suggests the market expects losses to narrow. Compared to the industry average, QuantumScape trades at a premium, but this is justified by its unique technology and potential market disruption. Historically, the PB ratio has ranged from 1.88 to 7.87, and the current 5.13 is near the higher end, suggesting the stock is not cheap on a book value basis.
PE
-13.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-16.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe. QuantumScape has no revenue, and its quarterly net losses of around $100 million are funded by cash reserves and external financing. The TTM free cash flow is -$281.7 million, implying a cash burn rate that could deplete its balance sheet within a few years if not replenished. While the current ratio of 15.95 provides near-term liquidity, the company's negative gross profit of -$14.76 million in Q1 2026 indicates that even its cost of goods sold exceeds any potential revenue, a structural issue that will persist until commercialization. The reliance on equity dilution to fund operations is a key risk, as seen in the increase in shares outstanding from 508 million in Q4 2024 to 611 million in Q1 2026, a 20% dilution that pressures existing shareholders.